Haldol (haloperidol)complete 2022

Drug classification - conventional antipsychotic Dose range - PO: 2-20 mg/daily in divided doses - IM: 2-5 mg. q1-8 hr, not to exceed 100 mg/day Depot injection: - Haloperidol Decanoate - 50 to 100 mg q4weeks 00:56 01:07 Pharmacological action - alters effect of dopamine in the CNS - has anticholinergic and alpha-adrenergic blocking activity Side effects/Adverse effects - seizures, extrapyramidal reactions, confusion - drowsiness, restlessness - tardive dyskinesia - blurred vision, respiratory depression - hypotension - constipation - dry mouth - sedation - tachycardia, urinary retention - neuroleptic malignant syndrome - agranulocytosis Medication/food interactions - antihypertensives= hypotension - CNS depressants = increased CNS depression - alcohol - anticholinergics - caffeine - carbamazepine Nursing interventions/client education - take as directed - may cause drowsiness - change positions slowly - possible extrapyramidal symptoms - avoid drinking alcohol - use sunscreen - drug impairs body temperature regulation - use frequent mouth rinse and good oral hygiene Therapeutic uses - diminished signs and symptoms of psychoses - improved behavior in children with Tourette's or other behavioral problems Nursing administration (concerns) - avoid skin contact with oral solution - PO administration with full glass of water or food to minimize GI irritation - IM: inject slowly via Z-track; do not exceed 3 ml per site - keep patient recumbent for at least 30 minutes following injection to minimize hypotensive effects Evaluation of Medication Effectiveness - decrease in hallucinations, insomnia, agitation, hostility and delusions - decreased tics and vocalization in Tourette's syndrome - improved behavior in children with severe behavior problems